Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical (LFCR) EBT: 2009-2025

Historic EBT for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to -$38.7 million.

  • Lifecore Biomedical's EBT rose 84.40% to -$1.1 million in Q2 2025 from the same period last year, while for May 2025 it was -$38.7 million, marking a year-over-year decrease of 506.50%. This contributed to the annual value of -$38.7 million for FY2025, which is 506.50% down from last year.
  • Per Lifecore Biomedical's latest filing, its EBT stood at -$38.7 million for FY2025, which was down 506.50% from $9.5 million recorded in FY2024.
  • In the past 5 years, Lifecore Biomedical's EBT ranged from a high of $9.5 million in FY2024 and a low of -$63.9 million during FY2023.
  • Over the past 3 years, Lifecore Biomedical's median EBT value was -$38.7 million (recorded in 2025), while the average stood at -$31.0 million.
  • As far as peak fluctuations go, Lifecore Biomedical's EBT soared by 114.88% in 2024, and later slumped by 506.50% in 2025.
  • Over the past 5 years, Lifecore Biomedical's EBT (Yearly) stood at -$29.8 million in 2021, then surged by 30.55% to -$20.7 million in 2022, then tumbled by 209.02% to -$63.9 million in 2023, then soared by 114.88% to $9.5 million in 2024, then tumbled by 506.50% to -$38.7 million in 2025.